Efficacy and safety of Methylnaltrexone Bromide treatment for opioid induced constipation in patients with non small cell lung cancer
Latest Information Update: 12 Nov 2017
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Adverse reactions; Therapeutic Use
- 18 Oct 2017 Results presented at the 18th World Conference on Lung Cancer.
- 27 Oct 2016 New trial record
- 01 Oct 2016 Results published in the Journal of Thoracic Oncology